FDA Inspection 1100022 — Azurity Pharmaceuticals, Inc.
The FDA completed an inspection of Azurity Pharmaceuticals, Inc. on Jul 26, 2019 in Woburn, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 26, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Woburn, MA (United States)